Spyre Therapeutics, Inc.

Ticker SYRE

Exchange NASDAQ More
Industry Biotechnology More
Sector Healthcare More

11-50 Employees
Based in San Francisco, California

Spyre Therapeutics is a biotechnology company that aims to create next-generation inflammatory bowel disease (IBD) products by combining best-in-class antibody engineering, rational therapeutic combinations, and precision medicine approaches. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23.

Visit website

REPORT RATINGS

4.7 / 5.0 (64)

Spyre Therapeutics, Inc. reports have an aggregate usefulness score of 4.7 based on 64 reviews.

Spyre Therapeutics, Inc.